ACT Signature Webinar (Delivered 9/2/2026)
Weight of Evidence Approaches for DART Assessments of Oligonucleotides: Current Reality and Future Considerations This presentation focuses on the regulatory
Conference Presentations, Regulatory Insights
DART Testing
Featured
Rethinking Clinical Trials for Pregnant and Breastfeeding Patients
Pregnant and breastfeeding individuals have long been excluded from clinical drug development, leaving physicians and patients to make critical treatment